Vamil Divan Stock Analyst Profile - Guggenheim Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vamil Divan

    Stock Analyst at Guggenheim

    (5)
    # 242
    Out of 5,470 analysts
    291
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Drug Manufacturers - General Drug Manufacturers - Specialty & Generic
    49 Stocks
    Name Action PT Current % Upside Ratings Updated
    VALN Valneva
    Maintains: Buy
    14 13
    		8.52 52.58% 2 Sep 8, 2025
    ANIP ANI Pharmaceuticals
    Maintains: Strong Buy
    86 114
    		95.2 19.75% 12 Sep 8, 2025
    INSM Insmed
    Maintains: Strong Buy
    125 172
    		146.68 17.26% 7 Sep 8, 2025
    ASMB Assembly Biosciences
    Maintains: Strong Buy
    31 39
    		23.32 67.24% 2 Sep 8, 2025
    ABBV AbbVie
    Maintains: Strong Buy
    216 227
    		209.94 8.13% 24 Aug 1, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    164 167
    		178.15 -6.26% 16 Jul 17, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Strong Buy
    6 7
    		2.16 224.07% 2 Jul 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    14
    		n/a n/a 1 Jun 16, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    9 8
    		3.85 107.79% 1 May 28, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Neutral
    288
    		280.19 2.79% 1 May 20, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    60
    		4.37 1273% 1 Apr 21, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    115 115
    		84.11 36.73% 9 Apr 17, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    47 47
    		21.2 121.7% 8 Apr 14, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    10 10
    		2.51 298.41% 3 Mar 20, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    n/a
    		n/a n/a 17 Mar 18, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Strong Buy
    59 61
    		24.75 146.46% 5 Feb 27, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    n/a
    		n/a n/a 5 Jan 17, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    7 4
    		3.65 -15.07% 6 Dec 10, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 2 Jun 18, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    55
    		64.97 -15.35% 1 Apr 9, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    245 330
    		329.83 0.05% 7 Jan 26, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    19 20
    		8.68 130.41% 9 Sep 7, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    21 18
    		40 -55% 2 Aug 18, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    26
    		1.6 1525% 2 Jun 15, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    35 40
    		40.39 -0.97% 3 Jun 12, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    8 9
    		0.92 878.26% 2 Apr 3, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Neutral
    n/a
    		n/a n/a 1 Mar 1, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    13 2
    		1.1 81.82% 5 Nov 15, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    27 19
    		25.39 -25.17% 7 Aug 10, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    95 98
    		143.8 -31.85% 8 Aug 8, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    36 34
    		28.45 19.51% 7 Jul 28, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    20 10
    		1.68 495.24% 3 May 25, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    51 49
    		129.29 -62.1% 3 May 3, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    315 356
    		738.59 -51.8% 15 May 2, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    8 6
    		7.77 -22.78% 1 Mar 16, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    144 154
    		14.49 962.8% 9 Mar 3, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    15
    		7.61 97.11% 5 May 6, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 6 Dec 13, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    7 4
    		n/a n/a 6 Nov 8, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    11 19
    		n/a n/a 8 Sep 17, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Neutral
    35
    		n/a n/a 13 Aug 5, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Neutral
    n/a
    		n/a n/a 13 Jul 10, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Outperform
    36 30
    		n/a n/a 4 May 21, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    161 155
    		n/a n/a 10 Mar 7, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Outperform
    15
    		5.9 154.24% 4 Aug 15, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    58 61
    		46.72 30.57% 5 Jul 27, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    103
    		2.51 4003.59% 3 Jan 17, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Outperform
    45 55
    		n/a n/a 1 Sep 19, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    66 120
    		n/a n/a 4 Dec 20, 2016